Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bal in the Treatment of Gold Toxicity.

Literature DB >> 18623786

Bal in the Treatment of Gold Toxicity.

J G Macleod¹.

Abstract

Entities: Disease Gene

Year: 1948 PMID： 18623786 PMCID： PMC1030591

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

× No keyword cloud information.

10 in total

1. The use and value of BAL in gold dermatitis.

Authors: G SLOT; A D McDONALD
Journal: Br Med J Date: 1947-11-15

2. METABOLISM, TOXICITY AND MANNER OF ACTION OF GOLD COMPOUNDS USED IN THE TREATMENT OF ARTHRITIS. I. HUMAN PLASMA AND SYNOVIAL FLUID CONCENTRATION AND URINARY EXCRETION OF GOLD DURING AND FOLLOWING TREATMENT WITH GOLD SODIUM THIOMALATE, GOLD SODIUM THIOSULFATE, AND COLLOIDAL GOLD SULFIDE.

Authors: R H Freyberg; W D Block; S Levey
Journal: J Clin Invest Date: 1941-07 Impact factor: 14.808

3. Treatment of gold dermatitis by BAL.

Authors: N R W SIMPSON
Journal: Br Med J Date: 1948-03-20

4. BAL (BRITISH ANTI-LEWISITE).

Authors: L L Waters; C Stock
Journal: Science Date: 1945-12-14 Impact factor: 47.728

5. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). XI. THE TREATMENT OF ACUTE MERCURY POISONING BY BAL.

Authors: W T Longcope; J A Luetscher; E Calkins; D Grob; S W Bush; H Eisenberg
Journal: J Clin Invest Date: 1946-07 Impact factor: 14.808

6. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). III. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION.

Authors: M B Sulzberger; R L Baer; A Kanof
Journal: J Clin Invest Date: 1946-07 Impact factor: 14.808

7. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VII. THE TREATMENT OF ARSENICAL DERMATITIS WITH PREPARATIONS OF BAL.

Authors: W T Longcope; J A Luetscher; M M Wintrobe; V Jäger
Journal: J Clin Invest Date: 1946-07 Impact factor: 14.808

8. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). II. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN NORMAL SUBJECTS AND AFTER MINIMAL EXPOSURE TO ARSENICAL SMOKE.

Authors: J Wexler; H Eagle; H J Tatum; H J Magnuson; E B Watson
Journal: J Clin Invest Date: 1946-07 Impact factor: 14.808

9. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). IV. PHARMACOLOGIC OBSERVATIONS ON BAL BY INTRAMUSCULAR INJECTION IN MAN.

Authors: W Modell; H Gold; M Cattell
Journal: J Clin Invest Date: 1946-07 Impact factor: 14.808

10. Effect of Some Sulfhydryl-containing Substances on the Toxicity of an Organic Mercurial Compound.

Authors: W K Long; A Farah
Journal: Science Date: 1946-09-06 Impact factor: 47.728

10 in total

5 in total

1. Thrombocytopenic purpura after administration of gold; comparison of treatment with dimercaprol, A.C.T.H., and cortisone.

Authors: M THOMPSON; R J SINCLAIR; J J DUTHIE
Journal: Br Med J Date: 1954-04-17